SKP2 and reading: Based on our pan-cancer study, increased SKP2 was a risk factor for the prognosis (OS, DSS, DFI, and/or PFI) of individuals with one of ten types of cancers — ACC, KICH, KIRP, LGG, LIHC, MESO, PRAD, SKCM, THCA, and UVM — while it predicted a favorable prognosis in READ, THYM, and OV patients.